Clinical Trial

Calcium Channel Blocker Amlodipine for Endometrial Cancer Therapy

Name: Calcium Channel Blocker Amlodipine for Endometrial Cancer Therapy — clinical trial record (NCT06942377)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

To explore the treatment efficacy of Progesterone Therapeutic Regimen Plus Amlodipine in patients with early endometrial carcinoma (EEC) for conservative treatment.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-04-16.

Trial Details

NCT Number	NCT06942377
Lead Sponsor	Peking University People's Hospital
Conditions	Endometrial Cancer
Enrollment	140 participants
Start Date	2025-07-15
Primary Completion	2027-01-01 (estimated)
Study Completion	2027-12-01 (estimated)
Updated on ClinicalTrials.gov	2025-07-08